Evidence map›Paper›PMID 30343318›Full record

Trial reportIntensive care medicine2018

A multicenter randomized controlled trial of a 3-L/kg/min versus 2-L/kg/min high-flow nasal cannula flow rate in young infants with severe viral bronchiolitis (TRAMONTANE 2).

Christophe Milési, Anne-Florence Pierre, Anna Deho, Robin Pouyau, Jean-Michel Liet, Camille Guillot, Anne-Sophie Guilbert, Jérôme Rambaud, Astrid Millet, Mickael Afanetti and 18 more

3 registry-linked trialsAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Intensive care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 37 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 5 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02824744 nacompletednot on this map

Comparison Between 2l/Min/kg vs 3l/Min/kg in High Flow Nasal Cannula (HFNC) During the Initial Management of Severe Bronchiolitis in Infants

TypeinterventionalSponsorUniversity Hospital, MontpellierRan2016 to 2018Enrolled300ConditionsBronchiolitisArmstreatment by 2l/min/kg in High Flow Nasal cannula (HFNC), treatment by 3l/min/kg in High Flow Nasal cannula (HFNC)
NCT04245202 nacompletednot on this map

Comparison of High Flow Nasal Cannula and Standard Face Mask Oxygen Therapy in Children With Moderate and Severe Bronchiolitis; a Randomized Controlled Trial

TypeinterventionalSponsorEge UniversityRan2017 to 2020Enrolled87ConditionsAcute BronchiolitisArmsHFNCOT, St-FMOT
NCT06249009 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Impact of Increasing Flow Rates in High-flow Nasal Cannula and CPAP on Diaphragmatic Work in Newborn and Paediatric Population: Non-inferiority Study

TypeinterventionalSponsorUniversity Hospital, Clermont-FerrandRan2023 to 2025Enrolled80ConditionsRespiratory Insufficiency in Children, Newborn Rds, Nasal Cannula, CPAP VentilationArmsNon invasive ventilation
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 5 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. High-flow nasal cannula therapy for infants with bronchiolitis.The Cochrane database of systematic reviews · 2024
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. The effects of flow settings during high-flow nasal cannula oxygen therapy for neonates and young children.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  19. Article
  20. Acute Viral Bronchiolitis: A Narrative Review.Journal of pediatric intensive care · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 10 institutions in 1 country.

Christophe MilésiDepartment of Neonatal Medicine and Pediatric Intensive Care, Arnaud de Villeneuve University Hospital, 371 Avenue Doyen G Giraud, 34295, Montpellier Cedex 5, France.
Anne-Florence PierrePediatric Intensive Care Unit, Kremlin Bicêtre University Hospital, Paris, France.
Anna DehoPediatric Intensive Care Unit, Robert Debré University Hospital, Paris, France.
Robin PouyauPediatric Intensive Care Unit, Women-Mother-Child University Hospital, Lyon, France.
Jean-Michel LietPediatric Intensive Care Unit, Women-Child University Hospital, Nantes, France.
Camille GuillotPediatric Intensive Care Unit, Jeanne de Flandre University Hospital, Lille, France.
Anne-Sophie GuilbertPediatric Intensive Care Unit, Hautepierre University Hospital, Strasbourg, France.
Jérôme RambaudPediatric Intensive Care Unit, Armand Trousseau University Hospital, Paris, France.
Astrid MilletPediatric Intensive Care Unit, La Tronche University Hospital, Grenoble, France.
Mickael AfanettiPediatric Intensive Care Unit, Lenval University Hospital, Nice, France.
Julie GuichouxPediatric Intensive Care Unit, Children's University Hospital, Bordeaux, France.
Mathieu GenuiniPediatric Intensive Care Unit, Necker-Sick Children University Hospital, Paris, France.
Thierry MansirPediatric Intensive Care Unit, General Hospital of Pau, Pau, France.
Jean BergouniouxPediatric Intensive Care Unit, Raymond Poincaré University Hospital, Garches, France.
Fabrice MichelPediatric Intensive Care Unit, La Timone University Hospital, Marseille, France.
Marie-Odile MarcouxPediatric Intensive Care Unit, Children's University Hospital, Toulouse, France.
Julien BaleineDepartment of Neonatal Medicine and Pediatric Intensive Care, Arnaud de Villeneuve University Hospital, 371 Avenue Doyen G Giraud, 34295, Montpellier Cedex 5, France.
Sabine DurandDepartment of Neonatal Medicine and Pediatric Intensive Care, Arnaud de Villeneuve University Hospital, 371 Avenue Doyen G Giraud, 34295, Montpellier Cedex 5, France.
Philippe DurandPediatric Intensive Care Unit, Kremlin Bicêtre University Hospital, Paris, France.
Stéphane DaugerPediatric Intensive Care Unit, Robert Debré University Hospital, Paris, France.
Etienne JavouheyPediatric Intensive Care Unit, Women-Mother-Child University Hospital, Lyon, France.
Stéphane LeteurtrePediatric Intensive Care Unit, Jeanne de Flandre University Hospital, Lille, France.
Olivier BrissaudPediatric Intensive Care Unit, Children's University Hospital, Bordeaux, France.
Sylvain RenolleauPediatric Intensive Care Unit, Necker-Sick Children University Hospital, Paris, France.
Aurélie PortefaixINSERM, CIC1407, 69500, Bron, France.
Aymeric DouillardDepartment of Medical Information, Arnaud de Villeneuve University Hospital, Montpellier, France.
Gilles CambonieDepartment of Neonatal Medicine and Pediatric Intensive Care, Arnaud de Villeneuve University Hospital, 371 Avenue Doyen G Giraud, 34295, Montpellier Cedex 5, France. g-cambonie@chu-montpellier.fr.ORCID http://orcid.org/0000-0002-1360-7915
GFRUP Respiratory Study Group
Hôpital Arnaud de Villeneuve · FRHospices Civils de Lyon · FRHôpital Jeanne de Flandre · FRCentre Hospitalier De Pau · FRFondation Lenval · FRHôpital Robert-Debré · FRInserm · FRSorbonne Université · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FRHôpital Raymond-Poincaré · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHigh-flow nasal cannula (HFNC) therapy is increasingly proposed as first-line respiratory support for infants with acute viral bronchiolitis (AVB). Most teams use 2 L/kg/min, but no study compared different flow rates in this setting. We hypothesized that 3 L/kg/min would be more efficient for the initial management of these patients.

methodsA randomized controlled trial was performed in 16 pediatric intensive care units (PICUs) to compare these two flow rates in infants up to 6 months old with moderate to severe AVB and treated with HFNC. The primary endpoint was the percentage of failure within 48 h of randomization, using prespecified criteria of worsening respiratory distress and discomfort.

resultsFrom November 2016 to March 2017, 142 infants were allocated to the 2-L/kg/min (2L) flow rate and 144 to the 3-L/kg/min (3L) flow rate. Failure rate was comparable between groups: 38.7% (2L) vs. 38.9% (3L; p = 0.98). Worsening respiratory distress was the most common cause of failure in both groups: 49% (2L) vs. 39% (3L; p = 0.45). In the 3L group, discomfort was more frequent (43% vs. 16%, p = 0.002) and PICU stays were longer (6.4 vs. 5.3 days, p = 0.048). The intubation rates [2.8% (2L) vs. 6.9% (3L), p = 0.17] and durations of invasive [0.2 (2L) vs. 0.5 (3L) days, p = 0.10] and noninvasive [1.4 (2L) vs. 1.6 (3L) days, p = 0.97] ventilation were comparable. No patient had air leak syndrome or died.

conclusionIn young infants with AVB supported with HFNC, 3 L/kg/min did not reduce the risk of failure compared with 2 L/kg/min. This clinical trial was recorded on the National Library of Medicine registry (NCT02824744).

Indexed as

Critical CareBronchiolitis, ViralCannulaFemaleFranceHumansInfantInfant, NewbornIntensive Care Units, PediatricMaleOxygen Inhalation TherapyProspective StudiesRespiration, ArtificialTreatment FailureBronchiolitisHigh-flow nasal cannulaInfantNoninvasive ventilationOxygen inhalation therapyRandomized controlled trialRespiratory syncytial virusRespiratory therapy

Identifiers

PMID30343318
OpenAlexW2891308282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.